Phase 2 clinical trials involved 338 adults with obesity (BMI 30 or more) and overweight (BMI of 2729.99) with one or more weight-related conditions such as high blood pressure, high cholesterol levels, heart disease, and type 2 diabetes
Diabetes Therapy 15(7):16391646 Yabe D, et al (2020) Safety and efficacy of oral semaglutide versus dulaglutide in Japanese patients with type 2 diabetes (PIONEER 10): an open-label, randomised, active-controlled, phase 3a trial
Nausea : One of the most frequently reported side effects, nausea can be mild to moderate and may diminish over time as the body adjusts to the medication
Full administration routes and dosing windows
Finding proper GLP-1 side effects relief here requires choosing a pure osmotic option rather than falling into traditional fiber traps
What You Will Find Here: What Is Semaglutide and Why Is It So Popular